Literature DB >> 19373777

Increased APN/CD13 and acid aminopeptidase activities in head and neck squamous cell carcinoma.

Itxaro Pérez1, Adolfo Varona, Lorena Blanco, Javier Gil, Francisco Santaolalla, Aitor Zabala, Agustin Martínez Ibarguen, Jon Irazusta, Gorka Larrinaga.   

Abstract

BACKGROUND: Involvement of peptidases in carcinogenic processes of several tumor types has been investigated in recent years. Head and neck squamous cell carcinoma (HNSCC) is one of the most common cancers worldwide and accounts for more than 90% of all head and neck cancers. Increased understanding of its pathophysiology has led to implication of several proteinases, specially matrix metalloproteinases, in its genesis, growth, and dissemination. However, very little is known about involvement of peptidases in this neoplasm.
METHODS: Seventeen HNSCC tissue samples were selected for the study. Tumor and normal tissue samples were frozen for enzymatic study. The catalytic activity for a pool of peptidases (PSA, APN/CD13, APB, APA, Asp-AP, CAP, DPPIV/CD26, NEP/CD10, and PGI) was measured fluorometrically.
RESULTS: The activity of 2 cell surface aminopeptidases (APN/CD13 and APA) and a cytosolic aminopeptidase (Asp-AP) was significantly increased in HNSCC tissues.
CONCLUSIONS: These data show the involvement of cell surface and cytosolic peptidases in the mechanisms underlying HNSCC. (c) 2009 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19373777     DOI: 10.1002/hed.21099

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  8 in total

1.  LYP, a novel bestatin derivative, inhibits cell growth and suppresses APN/CD13 activity in human ovarian carcinoma cells more potently than bestatin.

Authors:  Jian-Jun Gao; Zu-Hua Gao; Cui-Rong Zhao; Yi Yuan; Shu-Xiang Cui; Xiao-Fan Zhang; Yan-Na Cheng; Wen-Fang Xu; Wei Tang; Xian-Jun Qu
Journal:  Invest New Drugs       Date:  2010-01-29       Impact factor: 3.850

2.  Aminopeptidase activities as prospective urinary biomarkers for bladder cancer.

Authors:  Jennifer M Taylor; Mariana Yaneva; Kevin Velasco; John Philip; Hediye Erdjument-Bromage; Irina Ostrovnaya; Hans G Lilja; Bernard H Bochner; Paul Tempst
Journal:  Proteomics Clin Appl       Date:  2014-03-31       Impact factor: 3.494

3.  Identification and characterization of novel inhibitors of Mammalian aspartyl aminopeptidase.

Authors:  Yuanyuan Chen; Hong Tang; William Seibel; Ruben Papoian; Ki Oh; Xiaoyu Li; Jianye Zhang; Marcin Golczak; Krzysztof Palczewski; Philip D Kiser
Journal:  Mol Pharmacol       Date:  2014-06-09       Impact factor: 4.436

4.  Altered Activity and Expression of Cytosolic Peptidases in Colorectal Cancer.

Authors:  Itxaro Perez; Lorena Blanco; Begoña Sanz; Peio Errarte; Usue Ariz; Maider Beitia; Ainhoa Fernández; Alberto Loizate; M Luz Candenas; Francisco M Pinto; Javier Gil; José I López; Gorka Larrinaga
Journal:  Int J Med Sci       Date:  2015-06-02       Impact factor: 3.738

5.  Human mammospheres secrete hormone-regulated active extracellular vesicles.

Authors:  Esperanza Gonzalez; Marco Piva; Eva Rodriguez-Suarez; David Gil; Felix Royo; Felix Elortza; Juan M Falcon-Perez; Maria dM Vivanco
Journal:  PLoS One       Date:  2014-01-03       Impact factor: 3.240

6.  Silencing FLI or targeting CD13/ANPEP lead to dephosphorylation of EPHA2, a mediator of BRAF inhibitor resistance, and induce growth arrest or apoptosis in melanoma cells.

Authors:  Alireza Azimi; Rainer Tuominen; Fernanda Costa Svedman; Stefano Caramuta; Maria Pernemalm; Marianne Frostvik Stolt; Lena Kanter; Pedram Kharaziha; Janne Lehtiö; Carolina Hertzman Johansson; Veronica Höiom; Johan Hansson; Suzanne Egyhazi Brage
Journal:  Cell Death Dis       Date:  2017-08-31       Impact factor: 8.469

7.  MicroRNA-145 inhibits the proliferation, migration and invasion of the human TCA8113 oral cancer line.

Authors:  Yuan Shao; Shao-Qiang Zhang; Fang Quan; Peng-Fei Zhang; Sheng-Li Wu
Journal:  Oncol Lett       Date:  2013-10-11       Impact factor: 2.967

8.  Altered peptidase activities in thyroid neoplasia and hyperplasia.

Authors:  Gorka Larrinaga; Lorena Blanco; Peio Errarte; Maider Beitia; Begoña Sanz; Itxaro Perez; Amaia Irazusta; Clara E Sánchez; Francisco Santaolalla; Leire Andrés; José I López
Journal:  Dis Markers       Date:  2013-11-27       Impact factor: 3.434

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.